Prevalence of Adverse Events in Children With Congenital Hyperinsulinism Treated With Diazoxide

CONTEXT: Diazoxide, the only U.S. Food and Drug Administration–approved drug to treat hyperinsulinemic hypoglycemia, has been associated with several adverse events, which has raised concerns about the safety of this drug. Existing reports are limited to small studies and case reports. OBJECTIVE: To...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:J Clin Endocrinol Metab
Hauptverfasser: Herrera, Adriana, Vajravelu, Mary Ellen, Givler, Stephanie, Mitteer, Lauren, Avitabile, Catherine M, Lord, Katherine, De León, Diva D
Format: Artigo
Sprache:Inglês
Veröffentlicht: Endocrine Society 2018
Schlagworte:
Clinical Research Articles
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6207144/
https://ncbi.nlm.nih.gov/pubmed/30247666
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/jc.2018-01613
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge